id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-N-0386-0007,FDA,FDA-2014-N-0386,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2021-03-26T04:00:00Z,2021,3,2021-03-26T04:00:00Z,,2021-03-26T13:50:19Z,2021–06266,0,0,0900006484a7eb64
FDA-2014-N-0386-0005,FDA,FDA-2014-N-0386,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Orphan Drugs,Notice,30 Day Proposed Information Collection,2020-12-23T05:00:00Z,2020,12,2020-12-23T05:00:00Z,2021-01-23T04:59:59Z,2021-01-23T02:02:30Z,2020-28349,0,0,09000064849c0f39
FDA-2014-N-0386-0003,FDA,FDA-2014-N-0386,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Orphan Drugs",Notice,60 Day Proposed Information Collection,2020-10-02T04:00:00Z,2020,10,2020-10-02T04:00:00Z,2020-12-02T04:59:59Z,2020-12-02T02:01:35Z,2020-21843,0,0,09000064848b4f92
FDA-2014-N-0386-0002,FDA,FDA-2014-N-0386,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Orphan Drugs;
Common European Medicines Agency/ Food and Drug Administration
Application Form for Orphan Medicinal Product Designation",Notice,General Notice,2014-10-07T04:00:00Z,2014,10,2014-10-07T04:00:00Z,2014-11-07T04:59:59Z,2014-10-07T15:58:23Z,2014-23846,0,0,09000064818af03d
FDA-2014-N-0386-0001,FDA,FDA-2014-N-0386,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Orphan Drugs Products: Common European
Medicines Agency/Food and Drug Administration Application Form for
Orphan Medicinal Product Designation",Notice,General Notice,2014-04-16T04:00:00Z,2014,4,2014-04-16T04:00:00Z,2014-06-17T03:59:59Z,2014-04-16T15:10:51Z,2014-08589,0,0,09000064816b5dd5